Randomized trial · people

HGH: weekly Pegpesen matched daily rhGH on growth in children

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In children with GHD, a once-weekly pegylated growth hormone kept pace with daily shots on first-year growth, with similar safety.

Kind
Randomized trial
Studied in
People
Number studied
391
Published
2025
Journal
J Clin Endocrinol Metab

What they tested

The team tested whether Pegpesen, a once-weekly long-acting form of growth hormone, works as well and is as safe as daily growth hormone shots in children with growth hormone deficiency (GHD).

How the study was done

A randomized, controlled phase 3 trial at 23 centers in China in 391 children with GHD, assigned 2:1 to weekly Pegpesen (140 μg/kg/week) or daily rhGH, a lab-made human growth hormone (245 μg/kg/week), for 52 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking HGH? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At 52 weeks, growth velocity (how fast a child grows in height per year) was 9.910 cm/year with weekly Pegpesen and 10.037 cm/year with daily rhGH. The gap between groups was -0.127 (95% CI, -0.4868 to 0.2332), which met the trial's test for noninferiority, meaning the weekly shot was not meaningfully worse. Changes in height scores compared with children of the same age and the same bone age showed no significant difference between the groups. Safety and how well children stuck to treatment were also comparable.

What it doesn’t show

The trial lasted 52 weeks and was run only in China, so it doesn't show effects on final adult height or longer-term safety. It tested children with GHD, not adults or other uses of growth hormone.

The paper

Liang et al. A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency. J Clin Endocrinol Metab. 2025.

The compound

More studies on HGH

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking HGH? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo